COEP (Coeptis Therapeutics Holdings) Total Assets: $16.15 Mil (As of Dec. 2025)


COEP Coeptis Therapeutics Holdings Inc COEP
12 GF Score
Price $16.40
View Full Analysis

What is Coeptis Therapeutics Holdings Total Assets?

Coeptis Therapeutics Holdings COEP +1.52% 12 Total Assets is $16.15 Mil as of Dec. 2025. GuruFocus rates COEP with a GF Score™ of 12/100.

Coeptis Therapeutics Holdings's Total Assets for the quarter that ended in Dec. 2025 was $16.15 Mil.

During the past 12 months, Coeptis Therapeutics Holdings's average Total Assets Growth Rate was 17.00% per year. During the past 3 years, the average Total Assets Growth Rate was 33.40% per year. During the past 5 years, the average Total Assets Growth Rate was 102.00% per year.

During the past 6 years, Coeptis Therapeutics Holdings's highest 3-Year average Total Assets Growth Rate was 217.40%. The lowest was 22.20%. And the median was 33.40%.

Total Assets is connected with ROA %. Coeptis Therapeutics Holdings's annualized ROA % for the quarter that ended in Dec. 2025 was -41.61%. Total Assets is also linked to Revenue through Asset Turnover. Coeptis Therapeutics Holdings's Asset Turnover for the quarter that ended in Dec. 2025 was 0.06.

Coeptis Therapeutics Holdings  (NAS:COEP) Total Assets Explanation

Total Assets is connected with ROA %.

Coeptis Therapeutics Holdings's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-6.312/( (14.182+16.154)/ 2 )
=-6.312/15.168
=-41.61 %

Note: The Net Income data used here is four times the quarterly (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Coeptis Therapeutics Holdings's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0.862/( (14.182+16.154)/ 2 )
=0.862/15.168
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Coeptis Therapeutics Holdings Total Assets Related Terms

Coeptis Therapeutics Holdings Total Assets Historical Data

* Premium members only.

The historical data trend for Coeptis Therapeutics Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coeptis Therapeutics Holdings Total Assets Chart

Coeptis Therapeutics Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial 6.77 7.92 4.57 8.91 16.15

Coeptis Therapeutics Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.91 13.45 12.19 14.18 16.15
COEP
12GF Score
Coeptis Therapeutics Holdings Inc COEP
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coeptis Therapeutics Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Coeptis Therapeutics Holdings's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=14.068+2.086
=16.15

Coeptis Therapeutics Holdings's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=14.068+2.086
=16.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $16.15 Mil mean?
Coeptis Therapeutics Holdings (COEP) has a Total Assets of $16.15 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Coeptis Therapeutics Holdings and its competitors.
Is Coeptis Therapeutics Holdings' Total Assets too high?
Coeptis Therapeutics Holdings' current Total Assets is $16.15 Mil. Overall, Coeptis Therapeutics Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Coeptis Therapeutics Holdings' Total Assets compare to ANIX and COYA?
Coeptis Therapeutics Holdings' Total Assets of $16.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Coeptis Therapeutics Holdings and its competitors. Coeptis Therapeutics Holdings's current Total Assets is $16.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coeptis Therapeutics Holdings stock overvalued right now?
Coeptis Therapeutics Holdings (COEP) has a current Total Assets of $16.15 Mil. The current Total Assets is $16.15 Mil. Coeptis Therapeutics Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Coeptis Therapeutics Holdings (COEP), the current Total Assets is $16.15 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Coeptis Therapeutics Holdings Business Description

Address 105 Bradford Road, Suite 420, Wexford, PA, USA, 15090
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.
12GF Score

Get the complete analysis for COEP

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.40
Price